Financhill
Back

ADMA Biologics 10K Form

Buy
89

ADMA
ADMA Biologics

Last Price:
13.75
Seasonality Move:
-2.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADMA News And Ratings

See the #1 stock for the next 7 days that we like better than ADMA

ADMA Financial Statistics

Sales & Book Value

Annual Sales: $258.22M
Cash Flow: $-4.58M
Price / Cash Flow: 196.73
Annual Sales: $0.66
Price / Book: 20.74

Profitability

EPS (TTM): -0.02000
Net Income (TTM): $-3.64M
Gross Margin: $88.94M
Return on Equity: -2.49%
Return on Assets: -1.06%

ADMA Biologics Earnings Forecast

Key ADMA Biologics Financial Ratios

  • The Gross Profit Margin over the past 14 years for ADMA is 34.44%.
  • The Selling, General & Administrative Expenses for ADMA have been equal to 22.86% of Gross Profit Margin.
  • The Research & Development expenses have been 1.28% of Revenue.
  • The Interest Expense is -88.63% of Operating Income.
  • The Net Earning history of ADMA is -10.94% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 9 years.

ADMA Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADMA
CUSIP: 000899
Website: admabiologics.com

Debt

Debt-to-Equity Ratio: 0.85
Current Ratio: 5.21
Quick Ratio: 1.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 25.35

ADMA Technical Analysis vs Fundamental Analysis

Buy
89
ADMA Biologics (ADMA) is a Buy

Is ADMA Biologics a Buy or a Sell?

  • ADMA Biologics stock is rated a Buy
    The current ADMA Biologics [ADMA] share price is $13.75. The Score for ADMA is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.